Dopamine promotes α‐synuclein aggregation into SDS‐resistant soluble oligomers via a distinct folding pathway

Abstract
SPECIFIC AIMSThe pathological hallmark of Parkinson’s disease (PD) is the loss of dopamine producing neurons in the substantia nigra and the formation of intraneuronal Lewy bodies. Aggregated α-synuclein (α-SN) protein is the major component of the Lewy body. The aim of this work is to determine whether DA modulates the behavior of α-SN by studying the effect of DA on α-SN oligomerization. This would provide an important link between these two PD-associated molecules.PRINCIPAL FINDINGS1. Dopamine promotes α-SN oligomerization into SDS-resistant soluble oligomeric speciesThe association of α-SN aggregates within dopaminergic neurons in PD prompted us to investigate the effect of DA on α-SN oligomerization. Incubating recombinant wild-type human α-SN (14 μM) with increasing concentrations of DA for up to 3.5 h caused a time- and dose-dependent increase in SDS-resistant α-SN oligomers. DA mediated α-SN oligomers are rapidly formed and were readily detected after only 5 min with both 100 and 200 μM DA. While ...
Funding Information
  • National Health and Medical Research Council